250 related articles for article (PubMed ID: 19961757)
21. Podoplanin and E-cadherin expression in preoperative incisional biopsies of oral squamous cell carcinoma is related to lymph node metastases.
Foschini MP; Leonardi E; Eusebi LH; Farnedi A; Poli T; Tarsitano A; Cocchi R; Marchetti C; Gentile L; Sesenna E; Marucci G; Montebugnoli L
Int J Surg Pathol; 2013 Apr; 21(2):133-41. PubMed ID: 23349470
[TBL] [Abstract][Full Text] [Related]
22. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
[TBL] [Abstract][Full Text] [Related]
23. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
[TBL] [Abstract][Full Text] [Related]
24. Podoplanin expression in advanced-stage gastric carcinoma and prognostic value of lymphatic microvessel density.
Raica M; Ribatti D; Mogoanta L; Cimpean AM; Ioanovici S
Neoplasma; 2008; 55(5):455-60. PubMed ID: 18665758
[TBL] [Abstract][Full Text] [Related]
25. Proliferative verrucous leukoplakia, squamous cell carcinoma and axillary metastasis.
Gouvêa AF; Moreira AE; Reis RR; de Almeida OP; Lopes MA
Med Oral Patol Oral Cir Bucal; 2010 Sep; 15(5):e704-8. PubMed ID: 20173705
[TBL] [Abstract][Full Text] [Related]
26. Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance.
dos Santos Almeida A; Oliveira DT; Pereira MC; Faustino SE; Nonogaki S; Carvalho AL; Kowalski LP
Anticancer Res; 2013 Sep; 33(9):3969-76. PubMed ID: 24023336
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
28. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
Miyahara M; Tanuma J; Sugihara K; Semba I
Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-alpha overexpression in proliferative verrucous leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
Kannan R; Bijur GN; Mallery SR; Beck FM; Sabourin CL; Jewell SD; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jul; 82(1):69-74. PubMed ID: 8843456
[TBL] [Abstract][Full Text] [Related]
30. [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma].
Liu YM; Huang JH; Feng DY; Guo XC
Ai Zheng; 2005 Nov; 24(11):1354-7. PubMed ID: 16552962
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of podoplanin in oral cancer and its association with poor clinical outcome.
Yuan P; Temam S; El-Naggar A; Zhou X; Liu DD; Lee JJ; Mao L
Cancer; 2006 Aug; 107(3):563-9. PubMed ID: 16804930
[TBL] [Abstract][Full Text] [Related]
32. [Effects of Podoplanin on cell proliferation and cell cycle in oral leukoplakia cells].
Sun Q; Yan M; Zhou XJ; Li XM; Mao L; Chen WT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Jan; 45(1):6-10. PubMed ID: 20368032
[TBL] [Abstract][Full Text] [Related]
33. Overexpression and altered subcellular localization of autophagy-related 16-like 1 in human oral squamous-cell carcinoma: correlation with lymphovascular invasion and lymph-node metastasis.
Nomura H; Uzawa K; Yamano Y; Fushimi K; Ishigami T; Kouzu Y; Koike H; Siiba M; Bukawa H; Yokoe H; Kubosawa H; Tanzawa H
Hum Pathol; 2009 Jan; 40(1):83-91. PubMed ID: 18789482
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of cytokeratin proteins during tumour progression in oral mucosa.
Kannan S; Balaram P; Chandran GJ; Pillai MR; Mathew B; Nalinakumari KR; Nair MK
Epithelial Cell Biol; 1994; 3(2):61-9. PubMed ID: 7528604
[TBL] [Abstract][Full Text] [Related]
35. Podoplanin expression in oral leukoplakia: prognostic value and clinicopathological implications.
Kreppel M; Kreppel B; Drebber U; Wedemayer I; Rothamel D; Zöller JE; Scheer M
Oral Dis; 2012 Oct; 18(7):692-9. PubMed ID: 22471854
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
Fan GK; Chen J; Ping F; Geng Y
Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical Study of TGF-β1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma: Correlations Between Clinicopathologic Factors and Overall Survival.
Wagner VP; Cardoso PR; Dos Santos JN; Meurer L; Vargas PA; Fonseca FP; Carrard VC; Martins MD
Appl Immunohistochem Mol Morphol; 2017 Oct; 25(9):651-659. PubMed ID: 26990749
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma.
Lin L; Wang J; Liu D; Liu S; Xu H; Ji N; Zhou M; Zeng X; Zhang D; Li J; Chen Q
Sci Rep; 2016 May; 6():26757. PubMed ID: 27225603
[TBL] [Abstract][Full Text] [Related]
39. Podoplanin expression predicts prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy.
Kreppel M; Drebber U; Wedemeyer I; Eich HT; Backhaus T; Zöller JE; Scheer M
Oral Oncol; 2011 Sep; 47(9):873-8. PubMed ID: 21767977
[TBL] [Abstract][Full Text] [Related]
40. [Expression of integrin-beta1 in oral leukoplakia and early invasive carcinoma and its relationship with cell proliferation].
Shang JW; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Oct; 43(10):608-11. PubMed ID: 19087624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
